Reduction of serum thymus and activation-regulated chemokine after short-term intensive therapy may predict better prognosis of moderate to severe atopic dermatitis

J Dermatol. 2019 Dec;46(12):e486-e487. doi: 10.1111/1346-8138.15036. Epub 2019 Aug 2.

Authors

Ryo Saito¹, Akio Tanaka¹, Takaaki Hiragun¹, Kazumasa Iwamoto¹, Shunsuke Takahagi¹, Masakazu Takahashi², Michihiro Hide¹

Affiliations

¹ Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
² Graduate School of Innovation and Technology Management, Yamaguchi University, Yamaguchi, Japan.

PMID: 31376173
DOI: 10.1111/1346-8138.15036

No abstract available

Publication types

Letter

MeSH terms

Chemokine CCL17 / blood*
Dermatitis, Atopic / blood*
Dermatitis, Atopic / drug therapy
Humans
Remission Induction
Retrospective Studies

Substances

CCL17 protein, human
Chemokine CCL17